Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183076

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	296 552 EUR	—	—	—	—	—	322 528 EUR	—	—	—	—	—
Current assets	145 863 EUR	—	—	—	—	—	99 389 EUR	—	—	—	—	—
Non-current liabilities	278 298 EUR	—	—	—	—	—	292 285 EUR	—	—	—	—	—
Current liabilities	130 431 EUR	—	—	—	—	—	95 793 EUR	—	—	—	—	—
Revenue	—	—	—	66,997,000 EUR	—	—	—	—	—	—	22,668,000 EUR	—
Profit (loss)	—	—	—	59 620 EUR	59 620 EUR	—	—	—	—	—	116 875 EUR	116 875 EUR
Other comprehensive income	—	—	—	18 298 EUR	—	—	—	—	—	—	17 300 EUR	—
Comprehensive income	—	- EUR	18 298 EUR	77 918 EUR	59 620 EUR	- EUR	—	17 300 EUR	- EUR	- EUR	134 175 EUR	116 875 EUR